News
Headquartered in Pleasanton, California, Boster Biological Technology is making waves in the research community with its ...
CatalYmtoday announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage antibody visugromab can improve the anti-tumor activity of antibody-drug ...
Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special purpose acquisition company (SPAC) model to hop onto the Nasdaq.
Granite Bio is ready to rock 'n' roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting several autoimmune diseases. The funding consists of a $30 million series ...
UK production of cars, vans, trucks, taxis, buses and coaches increased by 17.1% to almost 80,000 units last month, when compared to March 2024. Car manufacturing grew for the first time in 12 ...
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting - Zai Lab will highlight potential of ZL-1310 as a promising ...
The water-soluble vitamins are vitamin C and vitamin B complex, which includes thiamine, riboflavin, niacin, pantothenic acid, pyridoxine, folate, biotin, and cobalamin. Vitamins can be fat ...
With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...
The latter occurs most notably in the neonate as a result of a mother with antibodies due to AITD. TPO antibodies (TPOAb) appear involved in the tissue destructive processes associated with the ...
ZL-1310 comprises a humanized anti-DLL3 monoclonal antibody connected via a cleavable linker to a novel camptothecin derivative (a topoisomerase 1 inhibitor) as its payload. The compound was designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results